My HPRA: Register

NUROFEN ADVANCE MAXIMUM STRENGTH

400 Milligram Oral Powder

Reckitt Benckiser Ireland LtdPA0979/032/014

Main Information

Trade NameNUROFEN ADVANCE MAXIMUM STRENGTH
Active SubstancesIBUPROFEN
Strength400 Milligram
Dosage FormOral Powder
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/032/014

Group Information

ATC CodeM01AE01 Propionic acid derivatives

Status

Authorised/WithdrawnAuthorised
Licence Issued23/03/2012
Supply StatusSupply through pharmacies only
Dispensing StatusProduct not subject to medical prescription
Marketing StatusNot Marketed
Promotion StatusPromotion to the general public
Conditions of LicenceProduct not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum strength 400 mg, maximum pack size 24, maximum dose: 400 mg, maximum daily dose 1200 mg, limited indications. For use in adults and chilren over 12 y

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.